• Publications
  • Influence
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
TLDR
Intraperitoneal cisplatin significantly improves survival and has significantly fewer toxic effects in patients with stage III ovarian cancer and residual tumor masses of 2 cm or less.
Tumors of the Uterine Isthmus: Clinicopathologic Features and Immunohistochemical Characterization of p53 Expression and Hormone Receptors
TLDR
Five endometrioid adenocarcinomas treated surgically between 1988 and 1992 were classified as primary isthmic tumors, and their clinicopathologic features and biologic behavior appeared similar to other high-grade endometrial cancers arising in the uterine corpus.
Multifractionated high-dose-rate brachytherapy with concomitant daily teletherapy for cervical cancer.
TLDR
Evaluating 88 patients treated for cervical carcinoma with HDR and external beam radiotherapy (EBRT) from August 1987 to December 1992 finds results compare favorably with previous LDR experience.
Postoperative radiation for cervical cancer with pathologic risk factors.
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin–cyclophosphamide versus carboplatin–cyclophosphamide in stages III (suboptimal) and IV
TLDR
The purpose of this study was to evaluate the effect of age on survival in a recently completed phase III Southwest Oncology Group study in ovarian cancer patients.
Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.
TLDR
Evaluation of drug interactions with isobolograms showed that at near-serum levels, carboplatin or cisplatin interacted synergistically with 1,25(OH)2D3 to inhibit MCF-7 cell growth.
Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone.
This study examined the growth inhibitory effects of combining 1,25-dihydroxyvitamin D3 (calcitriol) with retinoic acid or dexamethasone against cultured breast and ovarian carcinoma cells. Retinoic
...
...